{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:17:41Z","timestamp":1769757461234,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":296,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.rmcr.2022.101766","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T13:35:25Z","timestamp":1666704925000},"page":"101766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review"],"prefix":"10.1016","volume":"40","author":[{"given":"Jaleel Jerry G.","family":"Sweis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil William G.","family":"Sweis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ascoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boaz","family":"Avitall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kondos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Judson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawood","family":"Darbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonder","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Shahrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Leslie T.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadera J.","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmcr.2022.101766_bib1","article-title":"Sarcoidosis and autoimmunity","volume":"27","author":"Song","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmcr.2022.101766_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.107004","article-title":"Outcomes of prednisone-tapering regimens for cardiac sarcoidosis: a retrospective analysis demonstrating a benefit of infliximab","author":"Judson","year":"2022","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.rmcr.2022.101766_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/RLU.0000000000001124","article-title":"FDG PET\/CT evidence of effective treatment of cardiac sarcoidosis with adalimumab","volume":"41","author":"Miller","year":"2016","journal-title":"Clin. Nucl. Med."},{"issue":"4","key":"10.1016\/j.rmcr.2022.101766_bib4","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American thoracic society. European respiratory society. World association for sarcoidosis and other granulomatous disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmcr.2022.101766_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.rmcr.2022.101766_bib6","doi-asserted-by":"crossref","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann. Nucl. Cardiol."},{"issue":"2","key":"10.1016\/j.rmcr.2022.101766_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000001465","article-title":"Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high-protein, and very-low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"42","author":"Lu","year":"2017","journal-title":"Clin. Nucl. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2022.101766_bib8","article-title":"Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis","volume":"31","author":"Sweiss","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"7","key":"10.1016\/j.rmcr.2022.101766_bib9","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmcr.2022.101766_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2016.04.011","article-title":"Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab","volume":"115","author":"Crommelin","year":"2016","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmcr.2022.101766_bib11","article-title":"Controversies in the treatment of cardiac sarcoidosis","volume":"39","author":"Obi","year":"2022","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.rmcr.2022.101766_bib12","article-title":"C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis","volume":"27","author":"Sweiss","year":"2010","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.rmcr.2022.101766_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac sarcoidosis: the impact of age and implanted devices on survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmcr.2022.101766_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1371\/annotation\/a75007e1-492a-4bcb-80a8-28b4d432c099","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rmcr.2022.101766_bib15","article-title":"Does peripheral blood T-lymphocyte population distribution in sarcoidosis provide a prognostic clue?","volume":"8","author":"Desrues","year":"1991","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.rmcr.2022.101766_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3642832","article-title":"Local and systemic CD4+ T cell exhaustion reverses with clinical resolution of pulmonary sarcoidosis","author":"Hawkins","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.rmcr.2022.101766_bib17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1378\/chest.09-2576","article-title":"The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-\u03b1 therapy","volume":"137","author":"Crouser","year":"2010","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmcr.2022.101766_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2019.07.067","article-title":"Infliximab for refractory cardiac sarcoidosis","volume":"124","author":"Harper","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.rmcr.2022.101766_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2020.08.013","article-title":"Clinical and imaging response to tumor necrosis factor Alpha inhibitors in treatment of cardiac sarcoidosis: a multicenter experience","volume":"27","author":"Gilotra","year":"2021","journal-title":"J. Card. Fail."},{"issue":"3","key":"10.1016\/j.rmcr.2022.101766_bib20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.semarthrit.2019.11.004","article-title":"TNF-alpha inhibition for the treatment of cardiac sarcoidosis","volume":"50","author":"Baker","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.rmcr.2022.101766_bib21","first-page":"330","article-title":"Effectiveness and safety of infliximab in cardiac Sarcoidosis","author":"Bakker","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.rmcr.2022.101766_bib22","article-title":"Cardiac sarcoidosis: systematic review of literature on corticosteroid and immunosuppressive therapies","author":"Stievenart","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmcr.2022.101766_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-019-0235-z","article-title":"Macrophages are the primary effector cells in IL-7-induced arthritis","volume":"17","author":"Kim","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.rmcr.2022.101766_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044818","article-title":"Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.rmcr.2022.101766_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2012.12.016","article-title":"Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease","volume":"61","author":"Patterson","year":"2013","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.rmcr.2022.101766_bib26","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmcr.2022.101766_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmcr.2022.101766_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.676407","article-title":"Case report: TNF\u03b1 antagonists are an effective therapy in cardiac sarcoidosis","volume":"8","author":"Stievenart","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.rmcr.2022.101766_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.hrcr.2018.11.004","article-title":"Management of refractory ventricular tachycardia due to cardiac sarcoidosis\u2014a biologic approach","volume":"5","author":"Theodore","year":"2019","journal-title":"HeartRhythm Case Rep."},{"issue":"18","key":"10.1016\/j.rmcr.2022.101766_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.rmcr.2022.101766_bib31","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.healun.2020.08.001","article-title":"Tumor necrosis factor-\u03b1 inhibitor use for treatment of refractory cardiac sarcoidosis in a patient with left ventricular assist device: adalimumab use in refractory sarcoidosis in a patient with left ventricular assist device","volume":"39","author":"Krishnan","year":"2020","journal-title":"J. Heart Lung Transplant."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007122001885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007122001885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:06:18Z","timestamp":1761959178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007122001885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":31,"alternative-id":["S2213007122001885"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2022.101766","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2022.101766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101766"}}